Kineta rapidly advances leading-edge immunotherapeutic drug candidates through human safety trials, transacts with Pharma, 3 yr. est. to ROI
Kineta is a biotech company that fills a void in the pharma industry by advancing therapies from discovery to clinical proof of concept. We work with private, government and industry partners to advance our innovative research. Our unique funding model mitigates risk and may provide an attractive and earlier return for investors. Kineta has established and a pipeline of novel life improving therapies that address critical unmet patient needs.